Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 10/20 | 0.59 |
| ▸ | MAOB | P27338 | 10/20 | 0.59 |
| ▸ | ACHE | P22303 | 3/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.56 |
| ▸ | GRIN1 | Q05586 | 8/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 8/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 8/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29473625 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL31156397 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL30576402 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL30274268 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL1472359 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL4203950 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL25354476 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL2700651 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL29433776 | 1.00 | MAOA (0.59) | MAOAMAOBACHEFABP4FABP5 | |
| SCHEMBL351619 | 0.98 | FABP4 (0.58) | MAOAMAOBACHEFABP4FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112645971-B | Method for directly preparing alkyl borate compound from alkyl halide | 中国科学院兰州化学物理研究所 | 2021-12-24 | — | — | CN | claimed |
| US-20250185446-A1 | HOLE-TRANSPORTING SELF-ORGANISED MONOLAYER FOR PEROVSKITE SOLAR CELLS | HELMHOLTZ-ZENTRUM BERLIN FÜR MATERIALIEN UND ENERGIE GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| WO-2024085603-A1 | COMPOSITION FOR PREVENTING OR TREATING C-MYC-ASSOCIATED DISEASES THROUGH INHIBITION OF EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 47 (USP47), AND USE THEREOF | 이화여자대학교 산학협력단 | 2024-04-25 | — | — | WO | disclosed |
| WO-2023120963-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING CARBAZOLE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | 한국과학기술연구원 | 2023-06-29 | — | — | WO | disclosed |
| CN-112645971-B | Method for directly preparing alkyl borate compound from alkyl halide | 中国科学院兰州化学物理研究所 | 2021-12-24 | — | — | CN | disclosed |
| CN-112645971-A | Method for directly preparing alkyl borate compound from alkyl halide | 中国科学院兰州化学物理研究所 | 2021-04-13 | — | — | CN | disclosed |
| US-9663464-B2 | Carbazole derivatives acting on 5-HT7 receptor | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-05-30 | — | — | US | disclosed |
| US-20160244408-A1 | CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2016-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160244408-A1 | CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR | HTR7, HTR3A, HTR3B | MAOA 707/4885MAOB 762/4885ACHE 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.